World ADC USA 2026 in San Diego is the world's largest Antibody-Drug Conjugate event to progress ADCs in oncology and beyond. The conference focuses on innovating Novel Payload, Dual Payload, & Bispecific ADCs.
The 17th Annual World ADC USA will host more than 1,000 attendees from start-ups, biotechs, large pharma, and leading service providers to innovate, collaborate, and redefine the standard of oncology care for patients. Multiple streams of content span discovery chemistry, discovery biology, preclinical, translational medicine, clinical lessons, process and analytical development, and manufacturing & supply chain.
World ADC spotlights the cutting-edge innovation empowering the industry to develop differentiated ADCs that show clear advantages against standard-of-care therapies with clinically meaningful patient benefit.
AbbVie CDMO provides Biologics manufacturing services including Antibody Drug Conjugates. From drug development to final packaging, AbbVie Contract Manufacturing is a partner with decades of exerperience that can navigate the challenges of commercial ready production, regulatory compliance, and ongoing supply chain security.
Planning to attend World ADC USA 2026? Meet with our team at the event.
Event: World ADC USA 2026
Date: October 12-15, 2026
Location: San Diego, California, USA
